VERTEX PHARMACEUTICALS INC / MA ($VRTX)
Filing Information
| Accession Number | 0000875320-26-000096 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 19, 2026 |
| Document Date | Feb 17, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
7,929
Total Value
$1,035,225.00
P&L
+inf% (+$2,628,206.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP Chief Patient & Ext Af Off | Common Stock | โ | Feb 17, 2026 | Grant/Award | 5,789 | $0.00 | $0.00 | 71,182 | Direct | โ | View Details | |
EVP Chief Patient & Ext Af Off | Common Stock | โ | Feb 17, 2026 | Tax Withholding | 2,140 | $483.75 | $1,035,225.00 | 69,042 | Direct | โ | View Details |